Supplement Maker Timeline Raises $66M Amid Longevity Wave

A promising age-fighting ingredient in Timeline’s products has attracted big-time investors in L’Oréal and Nestlé

Consumer health biotech company Timeline has raised $66 million in a Series D financing round which included strategic investments from L’Oréal and Nestlé.

Switzerland-based Timeline offers nutritional supplements and topical skin health products with Mitopure, a proprietary ingredient (Urolithin A) that promotes healthy aging and is supported by 15-plus years of research, the company says.

The global corporate venture capital fund of L’Oréal led the funding round, which will go towards expanding Timeline’s product categories and markets across food, beauty and health while remaining longevity-focused. 

“This strategic collaboration reflects the breakthrough multidimensional approach that we’ve always believed is necessary to make meaningful advancements for longevity and healthspan,” said Patrick Aebischer, co-founder and chairman of Timeline. “I want to thank L’Oréal, Nestlé and our longstanding investors for their commitment to longevity solutions rooted in the highest level of science.”

Longevity is a new definition of beauty, points out Barbara Lavernos, deputy CEO who leads research, innovation and technology at L’Oréal.

“Longevity is about living healthier for longer, and L’Oréal has been working for a decade to understand and anticipate what this could mean for beauty,” Lavernos said. “Our investment in Timeline is exciting for its potential to transpose key hallmarks of longevity onto skin health and beauty.”

Timeline currently sells soft gel supplements and powder packets to promote energy, strength, and endurance, as well as a serum and day and night creams for the skin for youthfulness and radiance. All of Timeline’s products contain the recommended dose of Mitopure. 

“We have been an investor in Timeline since 2019 and continue to be very impressed with the team and stand behind the exponential potential that the Mitopure technology holds for nutrition to help people age better,” said Anna Mohl, CEO of Nestlé Health Science. “We’re excited to have L’Oréal join as an investor and strategic partner to bring this technology to new heights and extend its applications.”

Timeline’s Mitopure attracted one famous entrepreneur’s mom — Maye Musk, Elon’s mother. The dietitian promoted the company in 2021 when she signed on as spokesperson.

The post Supplement Maker Timeline Raises $66M Amid Longevity Wave appeared first on Athletech News.


您的电子邮箱地址不会被公开。 必填项已用 * 标注